跳至主要内容
临床试验/CTRI/2020/09/027567
CTRI/2020/09/027567尚未招募1 期

Efficacy of Mirena versus Ormeloxifene in management of Abnormal uterine bleeding (AUB) . - MIROR

Internal fluid research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women in the pre-menopausal age group who have Abnormal uterine bleeding.
  • Completed family/not desirous of conception.

排除标准

  • Patients with acute heavy bleeding requiring hospitalization and immediate treatment with hormones.
  • Patients requiring blood transfusion as a part of management.
  • Uterine size 14 weeks or more
  • Any fibroids pushing/indenting the endometrial cavity
  • Patients with Known blood dyscrasias / coagulopathies
  • Breast/genital tract malignancies
  • Adnexal mass
  • Endometrial polyp
  • Previous treatment with ormeloxifene
  • Clinical evidence of hepatic dysfunction, renal, cardiac or metabolic disorders.
  • Patients on concurrent treatment with other drugs for AUB.

研究者

发起方
Internal fluid research

相似试验